Assembly Biosciences (ASMB) Stock Research

Today

Assembly Biosciences reports Q2 EPS (20c), consensus (52c)

ASMB

4:04 PM

Over a week ago

Assembly Biosciences price target raised by $5 at Mizuho, here's why

ASMB

Jun 15, 6:57 AM

Assembly Biosciences announces expansion of ABI-6250 clinical development

ASMB

May 22, 7:05 AM

Assembly Biosciences reports Q1 EPS (54c), consensus (64c)

ASMB

May 7, 4:01 PM

Assembly Biosciences price target raised to $43 from $39 at Guggenheim

Apr 6, 6:42 AM

Assembly Biosciences files $400M mixed securities shelf

ASMB

Mar 19, 5:05 PM

Gilead opt-in 'significantly de-risks' Assembly pipeline, says H.C. Wainwright

Dec 22, 9:43 AM

Gilead exercises option to license Assembly helicase-primase inhibitor programs

Dec 22, 8:09 AM

Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials

Dec 8, 4:11 PM

Assembly Biosciences price target raised by $11 at Mizuho, here's why

ASMB

Nov 20, 7:09 AM

Assembly Biosciences reports Q3 EPS (72c), consensus (65c)

ASMB

Nov 10, 4:31 PM

Assembly Biosciences announces Phase 1b data for ABI-4334

ASMB

Nov 7, 8:05 AM

Assembly Biosciences files to sell 6.98M shares of commons stock for holders

ASMB

Oct 14, 4:22 PM

Assembly Biosciences presents interim Phase 1b data for ABI-5366

ASMB

Oct 10, 8:08 AM

Amazon upgraded, Adobe downgraded: Wall Street's top analyst calls

+13

Sep 24, 9:36 AM

Assembly Biosciences initiated with bullish view at Citizens JMP, here's why

ASMB

Sep 24, 4:29 AM

Assembly Biosciences price target raised by $8 at Guggenheim, here's why

ASMB

Sep 8, 7:43 AM

Four new option listings and one option delisting on August 27th

Aug 27, 8:30 AM

Assembly Biosciences assumed with a Buy at H.C. Wainwright

ASMB

Aug 18, 6:16 AM

No more stories